Top Markets
Coin of the day
AXIM Biotechnologies, Inc. AXIM Biotechnologies, Inc.

AXIM Biotechnologies, Inc.

AXIM
Rankning i aktier #37613
AXIM Biotechnologies, Inc. specializes in the creation and distribution of... AXIM Biotechnologies, Inc. specializes in the creation and distribution of advanced diagnostic solutions for healthcare, focusing on critical areas such as SARS-CoV-2 (COVID-19), ocular health, and cancer treatment. The company is currently developing rapid diagnostic assays that quantify functional neutralizing antibodies, which are essential for preventing the SARS-CoV-2 virus from attaching to human cells. Additionally, it offers serological diagnostic tests designed to detect neutralizing antibodies, thereby assessing the body's adaptive immune response to the virus, and is developing tests to identify inflammation biomarkers for the effective management of COVID-19 patients. For eye health, AXIM is pioneering quick, quantitative tear tests to measure Matrix metalloproteinase-9, an inflammatory marker associated with dry eye disease. In its oncology pipeline, the firm is advancing SBI-183, an anti-metastatic compound engineered to inhibit tumor cell growth and block the spread of cancer, as well as SPX-1009, another anti-metastatic therapy aimed at determining the levels of quiescin sulfhydryl oxidase I. Established in 2010, the company was formerly known as Axim International Inc. before officially changing its name to AXIM Biotechnologies, Inc. in July 2014, and it is headquartered in San Diego, California.
Aktiekurs
$0.0046
Senast synkroniserad: 2026-08-14
Marknadsvärde
$1.57M
Förändring (1 dag)
-8.00%
Förändring (1 år)
-9.80%
Land
US
Handel AXIM Biotechnologies, Inc. (AXIM)

Kategori

Antal utestående aktier för AXIM Biotechnologies, Inc. (AXIM)
Antal utestående aktier per August 2026: 0
Enligt de senaste finansiella rapporterna och aktiekursen för AXIM Biotechnologies, Inc. är det aktuella antalet utestående aktier 0. I slutet av August 2026 hade företaget 0 utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för AXIM Biotechnologies, Inc. (AXIM) från 2026 till 2026
Utestående aktier vid slutet av varje år
År Utestående aktier Ändra
Inte tillräckligt med data för de angivna datumen.
Utestående aktier för liknande företag eller konkurrenter
Företag Utestående aktier Skillnad Land
253.90M -
US
62.19M -
NL
- -
CH
- -
KR
0.00 -
BE